I have to agree on the valuation concern. I sold BUCY in the low 30's based upon a mid-teen forward PE and the prospect of their results lagging any recovery given their extended sales cycle. I made this same decision on several other long cycle companies and they have begun to disappoint, however BUCY has remarkably come through this quarter much better than expected.
Bucyrus: From Tepid to Bullish [View article]